Impel Pharmaceuticals Inc. (NASDAQ:IMPL) Sees Significant Gr

Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Approximately 5.5% of the shares of the stock are short sold. Based on […]

Related Keywords

United States , , Impel Pharmaceuticals Company Profile , Impel Pharmaceuticals , Impel Pharmaceuticals Trading Down , Nasdaq , Impel Pharmaceuticals Inc , News Ratings For Impel Pharmaceuticals Daily , Geode Capital Management , Institutional Trading Of Impel Pharmaceuticals , Mcdonald Partners , Raymond James Associates , Get Rating , Street Group , Capital Management , Pharmaceuticals Trading Down , Pharmaceuticals Inc , Impel Pharmaceuticals Daily , Nasdaq Impl , Simpl , Medical , Stocks , Options , Put , Call ,